ZYVERSA THERAPEUTICS, INC. Lease, Cost
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Lease, Cost of $89.00 thousand as of 2019-01-18, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Leases
us-gaap:LeaseCost · last filed 2026-05-13
- 2019-01-18: Lease, Cost $89.00K.
| Period end | Lease, Cost |
|---|---|
| 2019-01-18 | $89.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |